midazolam has been researched along with Dysthymia in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Excerpt | Relevance | Reference |
---|---|---|
" Comparing the EEG and motor seizure duration in the periods with and without midazolam, no significant differences were recorded, but the dosage of thiopental and of succinylcholine had to be increased markedly after midazolam was discontinued (P < 0." | 1.30 | Combining nefazodone and midazolam during ECT. ( al-Dubai, Z; Beraus, W; Conca, A; König, P, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conca, A | 1 |
al-Dubai, Z | 1 |
König, P | 1 |
Beraus, W | 1 |
1 other study available for midazolam and Dysthymia
Article | Year |
---|---|
Combining nefazodone and midazolam during ECT.
Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Drug Interactions; Dysthymic Di | 1999 |